Telomerase is a key enzyme for cell survival that prevents telomere shortening and the
subsequent cellular senescence that is observed after many rounds of cell division. In …

Liver cancer is one of the most common cancer types worldwide and the fourth leading
cause of cancer-related death. Liver carcinoma is distinguished by a high heterogeneity in …

Purpose To prospectively assess the threshold dose for objective response of hepatocellular
carcinoma (HCC), using 90 Y internal pair-production positron emission tomography (PET) …

Intratumoral neovascularization has intricate effects on tumor growth, metastasis, and
treatment. Over the last 30 years, Microvessel density (MVD) has been the standard method …

Hepatocellular carcinoma (HCC) is characterized by high prevalence of multifocality.
Multifocal HCC can arise synchronously or metachronously either from intrahepatic …

PURPOSE Hepatocellular carcinoma (HCC) is a highly heterogeneous disease, with more
than 40% of patients initially diagnosed with multinodular HCCs. Although circulating cell …

When do you need to take biopsies of the liver, and what information will you get is the topic
of this review on hepatocellular carcinoma (HCC). If, clinically, the differential diagnosis of …

The interferon-induced transmembrane protein 3 (IFITM3, also called 1‑8U) gene represents
dysregulated expression in various tumors and is involved in tumorigenesis and …

Background Few studies have focused on risk factors which may predict an intrahepatic
local recurrence (LR) on the surgical edge rather than a distant recurrence (DR) in other …

Background Hepatocellular carcinoma (HCC) ranks fifth among malignancies globally.
Previous studies have shown that systemic inflammatory response, platelet-to-lymphocyte …